Breaking Mladenov Criticizes Israel’s Gaza Actions, Cites Hindrance to U.S. Ceasefire Plan Eight Dead in Billings Home Fire, Authorities Investigate as Homicide Meta Reaches Up To $18 Billion Settlement Over Lawsuit Alleging Addictive Platform Design Affecting Children NFL Confirms Ineligibility for Players Returning to College Dolly Parton’s Life and Career Featured in Visual Retrospective

Wednesday August 26, 2026

Section

Press Releases

Press Release

NOBLE CORPORATION PLC ANNOUNCES SECOND QUARTER 2026 RESULTS

Noble Corporation plc · Jul 27

Press Release

GoPro Announces Second Quarter Earnings Webcast

GoPro, Inc. · Jul 27

Press Release

Harmonic Announces Reporting Date for Second Quarter 2026 Results

Harmonic Inc. · Jul 27

Press Release

TriNet Recognized as a Top Workplace by TIME, Newsweek and U.S. News & World Report

TriNet · Jul 27

Press Release

Community Solar Delivers Affordability Close to Home

The Pew Charitable Trusts · Jul 27

Press Release

Red Robin and Garage Beer Bring Kelce Brother-Owned Brand to Red Robin Restaurants Nationwide

Red Robin Gourmet Burgers, Inc. · Jul 27

Press Release

Northwest Bancshares, Inc. Announces Record Second Quarter 2026 GAAP net income of $54 million, or $0.36 per diluted share

Northwest Bancshares, Inc. · Jul 27

Press Release

Talos Energy Announces Strategic Offshore Mexico Development Farm-In

Talos Energy · Jul 27

Press Release

WEBTOON Entertainment Inc. to Report Second Quarter 2026 Financial Results on August 10, 2026

WEBTOON Entertainment Inc. · Jul 27

Press Release

CBNK Reports 2Q ROA of 1.52% and EPS of $0.87

Capital Bancorp, Inc. · Jul 27

Press Release

Slide Insurance Holdings, Inc. Initiates Quarterly Dividend

Slide Insurance Holdings, Inc. · Jul 27

Press Release

Scribe Therapeutics Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares, and Closing of the Concurrent Private Placement

Scribe Therapeutics Inc. · Jul 27

Press Release

ProMIS Neurosciences to Host Webinar to Discuss Upcoming 6-Month Blinded Interim Data from PRECISE-AD Phase 1b Trial of PMN310 in Alzheimer’s Disease

ProMIS Neurosciences Inc. · Jul 27

← Previous 1 … 3,347 3,348 3,349 … 3,721 Next →